{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:39:58Z","timestamp":1794008398677,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04815-6","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:01:44Z","timestamp":1751425304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mapping brain changes in post-COVID-19 cognitive decline via FDG PET hypometabolism and EEG slowing"],"prefix":"10.1038","volume":"15","author":[{"given":"Paolo","family":"Manganotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Iscra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Furlanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Michelutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Miladinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Menichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Cerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Accardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"Aj\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"4815_CR1","unstructured":"A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021)."},{"key":"4815_CR2","doi-asserted-by":"publisher","first-page":"n1648","DOI":"10.1136\/bmj.n1648","volume":"374","author":"H Crook","year":"2021","unstructured":"Crook, H., Raza, S., Nowell, J., Young, M. & Edison, P. Long covid\u2014mechanisms, risk factors, and management. BMJ 374, n1648 (2021).","journal-title":"BMJ"},{"key":"4815_CR3","doi-asserted-by":"publisher","first-page":"e2311974","DOI":"10.1001\/jamanetworkopen.2023.11974","volume":"6","author":"TC Liu","year":"2023","unstructured":"Liu, T. C. et al. Perceived cognitive deficits in patients with symptomatic SARS-CoV-2 and their association with post-COVID-19 condition. JAMA Netw. Open. 6, e2311974 (2023).","journal-title":"JAMA Netw. Open."},{"key":"4815_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27, 601\u2013615 (2021).","journal-title":"Nat. Med."},{"key":"4815_CR5","first-page":"100836","volume":"38","author":"M Quan","year":"2023","unstructured":"Quan, M. et al. Post-COVID cognitive dysfunction: current status and research recommendations for high risk population. Lancet Reg. Health West. Pac. 38, 100836 (2023).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"4815_CR6","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.tics.2023.08.008","volume":"27","author":"S Zhao","year":"2023","unstructured":"Zhao, S., Toniolo, S., Hampshire, A. & Husain, M. Effects of COVID-19 on cognition and brain health. Trends Cogn. Sci. 27, 1053\u20131067 (2023).","journal-title":"Trends Cogn. Sci."},{"key":"4815_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet, M., Geddes, J. R., Husain, M., Luciano, S. & Harrison, P. J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 8, 416\u2013427 (2021).","journal-title":"Lancet Psychiatry"},{"key":"4815_CR8","doi-asserted-by":"publisher","first-page":"19049","DOI":"10.1038\/s41598-024-69772-y","volume":"14","author":"L Kausel","year":"2024","unstructured":"Kausel, L. et al. Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations. Sci. Rep. 14, 19049 (2024).","journal-title":"Sci. Rep."},{"key":"4815_CR9","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s00259-021-05215-4","volume":"48","author":"E Guedj","year":"2021","unstructured":"Guedj, E. et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 48, 2823\u20132833 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4815_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/brain\/awab009","volume":"144","author":"JA Hosp","year":"2021","unstructured":"Hosp, J. A. et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 144, 1263\u20131276 (2021).","journal-title":"Brain"},{"key":"4815_CR11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2967\/jnumed.121.262128","volume":"62","author":"G Blazhenets","year":"2021","unstructured":"Blazhenets, G. et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J. Nucl. Med. 62, 910\u2013915 (2021).","journal-title":"J. Nucl. Med."},{"key":"4815_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00415-022-11543-8","volume":"270","author":"R Ferrucci","year":"2023","unstructured":"Ferrucci, R. et al. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19. J. Neurol. 270, 1823\u20131834 (2023).","journal-title":"J. Neurol."},{"key":"4815_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s00259-022-06013-2","volume":"50","author":"F Goehringer","year":"2023","unstructured":"Goehringer, F. et al. Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur. J. Nucl. Med. Mol. Imaging. 50, 1084\u20131089 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4815_CR14","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1097\/RLU.0000000000005614","volume":"50","author":"L Rozenblum","year":"2025","unstructured":"Rozenblum, L. et al. Cognitive impairment and brain metabolic changes in post-acute sequelae of COVID-19: insights from an [18 F]FDG PET\/CT cohort study. Clin. Nucl. Med. 50, e146\u2013e153 (2025).","journal-title":"Clin. Nucl. Med."},{"key":"4815_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3174\/ajnr.A7863","volume":"44","author":"P Debs","year":"2023","unstructured":"Debs, P. et al. Post-COVID-19 brain [18F] FDG-PET findings: A retrospective single-center study in the united States. Am. J. Neuroradiol. 44, 517\u2013522 (2023).","journal-title":"Am. J. Neuroradiol."},{"key":"4815_CR16","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1007\/s00259-024-06775-x","volume":"51","author":"T Horowitz","year":"2024","unstructured":"Horowitz, T. et al. Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [18F]FDG-PET study. Eur. J. Nucl. Med. Mol. Imaging. 51, 3215\u20133222 (2024).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4815_CR17","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.1038\/s41598-023-32275-3","volume":"13","author":"M Aj\u010devi\u0107","year":"2023","unstructured":"Aj\u010devi\u0107, M. et al. Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci. Rep. 13, 5808 (2023).","journal-title":"Sci. Rep."},{"key":"4815_CR18","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.3390\/s22176606","volume":"22","author":"M Kopa\u0144ska","year":"2022","unstructured":"Kopa\u0144ska, M. et al. Comparison of QEEG findings before and after onset of post-COVID-19 brain fog symptoms. Sens. (Basel). 22, 6606 (2022).","journal-title":"Sens. (Basel)"},{"key":"4815_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12883-023-03518-7","volume":"24","author":"MM Gaber","year":"2024","unstructured":"Gaber, M. M., Hosny, H., Hussein, M., Ashmawy, M. A. & Magdy, R. Cognitive function and quantitative electroencephalogram analysis in subjects recovered from COVID-19 infection. BMC Neurol. 24, 60 (2024).","journal-title":"BMC Neurol."},{"key":"4815_CR20","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3390\/biomedicines11082228","volume":"11","author":"P Ortelli","year":"2023","unstructured":"Ortelli, P. et al. Lowered delta activity in post-COVID-19 patients with fatigue and cognitive impairment. Biomedicines 11, 2228 (2023).","journal-title":"Biomedicines"},{"key":"4815_CR21","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s10072-023-06615-0","volume":"44","author":"G Furlanis","year":"2023","unstructured":"Furlanis, G. et al. Cognitive deficit in post-acute COVID-19: an opportunity for EEG evaluation? Neurol. Sci. 44, 1491\u20131498 (2023).","journal-title":"Neurol. Sci."},{"key":"4815_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.31083\/j.jin2305105","volume":"23","author":"A Gangemi","year":"2024","unstructured":"Gangemi, A., Suriano, R. & Fabio, R. A. Longitudinal exploration of cortical brain activity in cognitive fog: an EEG study in patients with and without anosmia. J. Integr. Neurosci. 23, 105 (2024).","journal-title":"J. Integr. Neurosci."},{"key":"4815_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3233\/ADR-230172","volume":"8","author":"W Wang","year":"2024","unstructured":"Wang, W., Cui, R., Leng, L., Wang, G. & Peng, G. Cognitive impairment in the post-acute phases of COVID-19 and mechanisms: an introduction and narrative review. J. Alzheimers Dis. Rep. 8, 647\u2013658 (2024).","journal-title":"J. Alzheimers Dis. Rep."},{"key":"4815_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clinph.2023.04.010","volume":"151","author":"P Manganotti","year":"2023","unstructured":"Manganotti, P., Michelutti, M., Furlanis, G. & Deodato, M. Buoite stella, A. Deficient GABABergic and glutamatergic excitability in the motor cortex of patients with long-COVID and cognitive impairment. Clin. Neurophysiol. 151, 83\u201391 (2023).","journal-title":"Clin. Neurophysiol."},{"key":"4815_CR25","doi-asserted-by":"publisher","first-page":"111186","DOI":"10.1016\/j.mehy.2023.111186","volume":"180","author":"T Horowitz","year":"2023","unstructured":"Horowitz, T., Pellerin, L., Zimmer, E. R. & Guedj, E. Brain fog in long COVID: A glutamatergic hypothesis with astrocyte dysfunction accounting for brain PET glucose hypometabolism. Med. Hypotheses. 180, 111186 (2023).","journal-title":"Med. Hypotheses"},{"key":"4815_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2017.06.009","volume":"58","author":"DV Moretti","year":"2017","unstructured":"Moretti, D. V. et al. Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha\/low-alpha frequency power ratio. Neurobiol. Aging. 58, 213\u2013224 (2017).","journal-title":"Neurobiol. Aging"},{"key":"4815_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/braincomms\/fcae227","volume":"6","author":"W Li","year":"2024","unstructured":"Li, W. et al. Data-driven retrieval of population-level EEG features and their role in neurodegenerative diseases. Brain Commun. 6, 227 (2024).","journal-title":"Brain Commun."},{"key":"4815_CR28","doi-asserted-by":"publisher","first-page":"102601","DOI":"10.1016\/j.nicl.2021.102601","volume":"30","author":"B Hermann","year":"2021","unstructured":"Hermann, B. et al. Multimodal FDG-PET and EEG assessment improves diagnosis and prognostication of disorders of consciousness. Neuroimage Clin. 30, 102601 (2021).","journal-title":"Neuroimage Clin."},{"key":"4815_CR29","doi-asserted-by":"publisher","first-page":"e200135","DOI":"10.1212\/CPJ.0000000000200135","volume":"13","author":"KS Husari","year":"2023","unstructured":"Husari, K. S. et al. EEG correlates of qualitative hypermetabolic FDG-PET in patients with neurologic disorders. Neurol. Clin. Pract. 13, e200135 (2023).","journal-title":"Neurol. Clin. Pract."},{"key":"4815_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0013-4694(94)90034-5","volume":"91","author":"B Szelies","year":"1994","unstructured":"Szelies, B., Mielke, R., Herholz, K. & Heiss, W. D. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia. Electroencephalogr. Clin. Neurophysiol. 91, 131\u2013139 (1994).","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"4815_CR31","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","volume":"36","author":"A Varrone","year":"2009","unstructured":"Varrone, A. et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur. J. Nucl. Med. Mol. Imaging. 36, 2103\u20132110 (2009).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4815_CR32","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00259-020-04825-8","volume":"47","author":"D Paez","year":"2020","unstructured":"Paez, D. et al. COVID-19 pandemic: guidance for nuclear medicine departments. Eur. J. Nucl. Med. Mol. Imaging. 47, 1615\u20131619 (2020).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4815_CR33","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s00259-020-05175-1","volume":"48","author":"SP Caminiti","year":"2021","unstructured":"Caminiti, S. P. et al. Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps. Eur. J. Nucl. Med. Mol. Imaging. 48, 2486\u20132499 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4815_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1027\/1015-5759\/a000217","volume":"31","author":"F Pirrotta","year":"2015","unstructured":"Pirrotta, F. et al. Italian validation of Montreal cognitive assessment. Eur. J. Psychol. Assess. 31, 131\u2013137 (2015).","journal-title":"Eur. J. Psychol. Assess."},{"key":"4815_CR35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal cognitive assessment, moca: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"4815_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s40520-021-01943-7","volume":"34","author":"EN Aiello","year":"2022","unstructured":"Aiello, E. N. et al. The Montreal cognitive assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy. Aging Clin. Exp. Res. 34, 375\u2013382 (2022).","journal-title":"Aging Clin. Exp. Res."},{"key":"4815_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2019.05.028","volume":"65","author":"M Siciliano","year":"2019","unstructured":"Siciliano, M. et al. Fatigue in parkinson\u2019s disease: Italian validation of the Parkinson fatigue scale and the fatigue severity scale using a Rasch analysis approach. Parkinsonism Relat. Disord. 65, 105\u2013110 (2019).","journal-title":"Parkinsonism Relat. Disord"},{"key":"4815_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/09658210244000027","volume":"11","author":"JR Crawford","year":"2003","unstructured":"Crawford, J. R., Smith, G., Maylor, E. A., Della Sala, S. & Logie, R. H. The prospective and retrospective memory questionnaire (PRMQ): normative data and latent structure in a large non-clinical sample. Memory 11, 261\u2013275 (2003).","journal-title":"Memory"},{"key":"4815_CR39","unstructured":"Derogatis, L., Sarno, I., Preti, E., Prunas, A. & Madeddu, F. Manuale di somministrazione e scoring. Adattamento italiano di SCL-90-R. https:\/\/boa.unimib.it\/handle\/10281\/23234 (2011)."},{"key":"4815_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12021-014-9235-4","volume":"12","author":"PA Della Rosa","year":"2014","unstructured":"Della Rosa, P. A. et al. A standardized [18F]-FDG-PET template for Spatial normalization in statistical parametric mapping of dementia. Neuroinformatics 12, 575\u2013593 (2014).","journal-title":"Neuroinformatics"},{"key":"4815_CR41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.nicl.2014.10.009","volume":"6","author":"D Perani","year":"2014","unstructured":"Perani, D. et al. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. Neuroimage Clin. 6, 445\u2013454 (2014).","journal-title":"Neuroimage Clin."},{"key":"4815_CR42","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s00259-020-05178-y","volume":"48","author":"A Kas","year":"2021","unstructured":"Kas, A. et al. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur. J. Nucl. Med. Mol. Imaging. 48, 2543\u20132557 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4815_CR43","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s00259-017-3761-x","volume":"44","author":"M Pagani","year":"2017","unstructured":"Pagani, M. et al. Early identification of MCI converting to AD: a FDG PET study. Eur. J. Nucl. Med. Mol. Imaging. 44, 2042\u20132052 (2017).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4815_CR44","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00259-017-3790-5","volume":"44","author":"S Morbelli","year":"2017","unstructured":"Morbelli, S. et al. 18F-FDG PET diagnostic and prognostic patterns do not overlap in alzheimer\u2019s disease (AD) patients at the mild cognitive impairment (MCI) stage. Eur. J. Nucl. Med. Mol. Imaging. 44, 2073\u20132083 (2017).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4815_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinph.2022.01.136","volume":"138","author":"P Polverino","year":"2022","unstructured":"Polverino, P. et al. Brain oscillatory patterns in mild cognitive impairment due to alzheimer\u2019s and parkinson\u2019s disease: an exploratory high-density EEG study. Clin. Neurophysiol. 138, 1\u20138 (2022).","journal-title":"Clin. Neurophysiol."},{"key":"4815_CR46","first-page":"704","volume":"24","author":"A Henri-Bhargava","year":"2018","unstructured":"Henri-Bhargava, A., Stuss, D. T. & Freedman, M. Clinical assessment of prefrontal lobe functions. Continuum: Lifelong Learn. Neurol. 24, 704 (2018).","journal-title":"Continuum: Lifelong Learn. Neurol."},{"key":"4815_CR47","first-page":"1586","volume":"27","author":"DT Jones","year":"2021","unstructured":"Jones, D. T. & Graff-Radford, J. Executive dysfunction and the prefrontal cortex. Continuum (Minneap Minn). 27, 1586\u20131601 (2021).","journal-title":"Continuum (Minneap Minn)"},{"key":"4815_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-022-11047-5","volume":"1","author":"G Cecchetti","year":"2022","unstructured":"Cecchetti, G. et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J. Neurol. 1, 1\u201313. https:\/\/doi.org\/10.1007\/s00415-022-11047-5 (2022).","journal-title":"J. Neurol."},{"key":"4815_CR49","doi-asserted-by":"publisher","first-page":"e2130645","DOI":"10.1001\/jamanetworkopen.2021.30645","volume":"4","author":"JH Becker","year":"2021","unstructured":"Becker, J. H. et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw. Open. 4, e2130645 (2021).","journal-title":"JAMA Netw. Open."},{"key":"4815_CR50","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/cells13201714","volume":"13","author":"P Shichkova","year":"2024","unstructured":"Shichkova, P., Coggan, J. S., Markram, H. & Keller, D. Brain metabolism in health and neurodegeneration: the iinterplay among neurons and astrocytes. Cells 13, 1714 (2024).","journal-title":"Cells"},{"key":"4815_CR51","doi-asserted-by":"crossref","unstructured":"Lejko, N., Larabi, D. I., Herrmann, C. S., Aleman, A. & \u0106ur\u010di\u0107-Blake, B. Alpha power and functional connectivity in cognitive decline: a systematic review and meta-analysis. J. Alzheimers Dis. 78, 1047\u20131088.","DOI":"10.3233\/JAD-200962"},{"key":"4815_CR52","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.3390\/cells12162019","volume":"12","author":"S Raut","year":"2023","unstructured":"Raut, S. et al. Hypometabolism, Alzheimer\u2019s disease, and possible therapeutic targets: an overview. Cells 12, 2019 (2023).","journal-title":"Cells"},{"key":"4815_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neurobiolaging.2019.10.004","volume":"85","author":"CSY Benwell","year":"2020","unstructured":"Benwell, C. S. Y. et al. EEG spectral power abnormalities and their relationship with cognitive dysfunction in patients with alzheimer\u2019s disease and type 2 diabetes. Neurobiol. Aging. 85, 83\u201395 (2020).","journal-title":"Neurobiol. Aging"},{"key":"4815_CR54","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3233\/JAD-210335","volume":"82","author":"S Toniolo","year":"2021","unstructured":"Toniolo, S. et al. Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care. J. Alzheimers Dis. 82, 883\u2013898 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"4815_CR55","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/brain\/awaa240","volume":"143","author":"RW Paterson","year":"2020","unstructured":"Paterson, R. W. et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 143, 3104\u20133120 (2020).","journal-title":"Brain"},{"key":"4815_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1191083","volume":"14","author":"R Bulla","year":"2023","unstructured":"Bulla, R. et al. A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients. Front. Immunol. 14, 1 (2023).","journal-title":"Front. Immunol."},{"key":"4815_CR57","first-page":"1","volume":"27","author":"MC Medori","year":"2023","unstructured":"Medori, M. C. et al. Serum proteomic profiling reveals potential inflammatory biomarkers in long-COVID patients: a comparative analysis with healthy controls. Eur. Rev. Med. Pharmacol. Sci. 27, 1\u201312 (2023).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"4815_CR58","doi-asserted-by":"publisher","first-page":"1465787","DOI":"10.3389\/fneur.2024.1465787","volume":"15","author":"GM Talkington","year":"2024","unstructured":"Talkington, G. M. et al. Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics. Front. Neurol. 15, 1465787 (2024).","journal-title":"Front. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04815-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:16:56Z","timestamp":1751437016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04815-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4815"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04815-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23141"}}